Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Read now
Rajeev K. Singla, Xiaoyan Wang, Rohit Gundamaraju, Shikha Joon, Christos Tsagkaris, Sahar Behzad, Johra Khan, Rupesh Gautam, Rajat Goyal, Jaruporn Rakmai, Ankit Kumar Dubey, Jesus Simal-Gandara & Bairong Shen. (2022) Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. Critical Reviews in Food Science and Nutrition 0:0, pages 1-45.
Read now
Read now
Hannat Akintomide & Sabeena Panicker. (2015) Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability. Open Access Journal of Contraception 6, pages 77-86.
Read now
Read now
Articles from other publishers (43)
Vera N. Prilepskaya & Lana L. Bostandzhian. (2023) Complex questions about combined hormonal contraception: A review. Gynecology 25:2, pages 251-257.
Crossref
Crossref
Shuqing Zou, Yuxiang Lin, Xingxing Yu, Mikael Eriksson, Moufeng Lin, Fangmeng Fu & Haomin Yang. (2023) Genetic and lifestyle factors for breast cancer risk assessment in Southeast China. Cancer Medicine 12:14, pages 15504-15514.
Crossref
Crossref
Herjan J. T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, V. Craig Jordan, Paula Briggs, Jan F. M. Egberts, Kristina Gemzell-Danielsson, Ludwig Kiesel, Kirsten Kluivers, Jan Krijgh, Tommaso Simoncini, Frank Z. Stanczyk & Robert D. Langer. (2023) Progesterone from ovulatory menstrual cycles is an important cause of breast cancer. Breast Cancer Research 25:1.
Crossref
Crossref
L.I. Maltseva & Yu.V. Garifullova. (2023) Long-term contraception with combined hormonal drugs until menopause. Benefits and risks. Problemy reproduktsii 29:5, pages 102.
Crossref
Crossref
Maria Alejandra Belardo, Pisula Pedro & Capalbo Olivia. (2022) Breast cancer and progestins in menopausal hormone therapy: a literature review. Obstetrics & Gynecology International Journal 13:2, pages 101-110.
Crossref
Crossref
Lusine Yaghjyan, Carmen Smotherman, John Heine, Graham A. Colditz, Bernard Rosner & Rulla M. Tamimi. (2022) Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women. Cancer Epidemiology, Biomarkers & Prevention 31:2, pages 436-442.
Crossref
Crossref
Sharmila Brabaharan, Sajesh K. Veettil, Jennifer E. Kaiser, Vrosha Rau Raja Rao, Rujira Wattanayingcharoenchai, Marikannan Maharajan, Putsarat Insin, Pattarawalai Talungchit, Thunyarat Anothaisintawee, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2022) Association of Hormonal Contraceptive Use With Adverse Health Outcomes. JAMA Network Open 5:1, pages e2143730.
Crossref
Crossref
Abhay K. Kattepur & K. S. Gopinath. 2022. Breast Cancer. Breast Cancer
353
397
.
Lisa Hackney. 2022. Digital Mammography. Digital Mammography
51
69
.
Akshata M. Kamath Ammembal & Karthik Udupa. (2021) Combined Oral Contraceptives and Breast Cancer: an Unsolved Conundrum. Indian Journal of Gynecologic Oncology 19:4.
Crossref
Crossref
Agnieszka Barańska, Agata Błaszczuk, Wiesław Kanadys, Maria Malm, Katarzyna Drop & Małgorzata Polz-Dacewicz. (2021) Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020. Cancers 13:22, pages 5654.
Crossref
Crossref
Jon G. Steller, Rebecca Blue, Christopher Zahner, Emily H. Frisch, Tina Bayuse, Serena Auñon-Chancellor & Richard T. Jennings. (2021) Menstrual management considerations in the space environment. REACH 23-24, pages 100044.
Crossref
Crossref
R. Bonfiglio & M.L. Di Pietro. (2021) The impact of oral contraceptive use on breast cancer risk: State of the art and future perspectives in the era of 4P medicine. Seminars in Cancer Biology 72, pages 11-18.
Crossref
Crossref
Serena C. Houghton & Susan E. Hankinson. (2021) Cancer Progress and Priorities: Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention 30:5, pages 822-844.
Crossref
Crossref
Tingting Zhao, Zihan Cui, Mary Grace McClellan, Disa Yu, Qing-Xiang Amy Sang & Jinfeng Zhang. (2020) Identifying county-level factors for female breast cancer incidence rate through a large-scale population study. Applied Geography 125, pages 102324.
Crossref
Crossref
Boyoung Park, Se-Eun Lim, HyoJin Ahn, Junghyun Yoon & Yun Su Choi. (2020) Heterogenous Effect of Risk Factors on Breast Cancer across the Breast Density Categories in a Korean Screening Population. Cancers 12:6, pages 1391.
Crossref
Crossref
Gianluca Franceschini, Alba Di Leone, Sabatino D’Archi & Riccardo Masetti. (2020) Oral contraceptives and breast cancer risk: An overestimated risk?. Critical Reviews in Oncology/Hematology 147, pages 102876.
Crossref
Crossref
Partha Basu, Li Zhang, Roopa Hariprasad, AndreL Carvalho & Anton Barchuk. (2020) A pragmatic approach to tackle the rising burden of breast cancer through prevention & early detection in countries 'in transition'. Indian Journal of Medical Research 152:4, pages 343.
Crossref
Crossref
Nicoletta Biglia, Valentina Elisabetta Bounous, Marta D’Alonzo, Michela Villa & Andrea Villasco. 2020. Female Reproductive Dysfunction. Female Reproductive Dysfunction
433
460
.
Nicoletta Biglia, Valentina Elisabetta Bounous, Marta D’Alonzo, Michela Villa & Andrea Villasco. 2020. Female Reproductive Dysfunction. Female Reproductive Dysfunction
1
29
.
Maria E. Arriaga, Claire M. Vajdic, Karen Canfell, Robert J. MacInnis, Emily Banks, Julie E. Byles, Dianna J. Magliano, Anne W. Taylor, Paul Mitchell, Graham G. Giles, Jonathan E. Shaw, Tiffany K. Gill, Elizabeth Klaes, Louiza S. Velentzis, Robert G. Cumming, Vasant Hirani & Maarit A. Laaksonen. (2019) The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study. International Journal of Cancer 145:9, pages 2383-2394.
Crossref
Crossref
I. V. Vуsotskaya, V. P. Letyagin, I. K. Vorotnikov, V. U. Kirsanov, I. A. Gladilina & E. A. Kim. (2019) Oral contraceptives and menopausal hormone therapy as breast cancer risk categories. Tumors of female reproductive system 15:2, pages 42-51.
Crossref
Crossref
Alison Vaughan. (2019) Providing contraception for perimenopausal women. Practice Nursing 30:4, pages 166-170.
Crossref
Crossref
Alison Vaughan. (2019) Providing contraception for perimenopausal women. Practice Nursing 30:4, pages 114-118.
Crossref
Crossref
. (2019) FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception. BMJ Sexual & Reproductive Health 45:Suppl 1, pages 1-93.
Crossref
Crossref
Li-Wei Ji, Chun-Xia Jing, Su-Lian Zhuang, Wei-Cheng Pan & Xing-Po Hu. (2019) Effect of age at first use of oral contraceptives on breast cancer risk. Medicine 98:36, pages e15719.
Crossref
Crossref
William V. Williams, Louise A. Mitchell, S. Kathleen Carlson & Kathleen M. Raviele. (2019) Association of Combined Estrogen–Progestogen and Progestogen-Only Contraceptives with the Development of Cancer. The Linacre Quarterly 85:4, pages 412-452.
Crossref
Crossref
Irene Zolfaroli, Juan J. Tarín & Antonio Cano. (2018) Hormonal contraceptives and breast cancer: Clinical data. European Journal of Obstetrics & Gynecology and Reproductive Biology 230, pages 212-216.
Crossref
Crossref
Ines Vaz-Luis & Ann H. Partridge. (2018) Exogenous reproductive hormone use in breast cancer survivors and previvors. Nature Reviews Clinical Oncology 15:4, pages 249-261.
Crossref
Crossref
Moon Kyoung Cho. (2018) Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Medical Journal 54:3, pages 153.
Crossref
Crossref
Helena Kopp Kallner. (2018) Benefits of reversible contraception. F1000Research 7, pages 973.
Crossref
Crossref
R. M. Parks, M. G. M. Derks, E. Bastiaannet & K. L. Cheung. 2018. Breast Cancer Management for Surgeons. Breast Cancer Management for Surgeons
19
29
.
Jo Marsden. (2017) Hormonal contraception and breast cancer, what more do we need to know?. Post Reproductive Health 23:3, pages 116-127.
Crossref
Crossref
R. Gabriel & A. Fevre. (2017) Anticoncepción estroprogestágena. EMC - Ginecología-Obstetricia 53:3, pages 1-12.
Crossref
Crossref
Jinghong Zhang, Lijun Zhang & Guangming Li. (2016) Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects. World Journal of Surgical Oncology 14:1.
Crossref
Crossref
Anton Pottegård, Søren Friis, René dePont Christensen, Laurel A. Habel, Joshua J. Gagne & Jesper Hallas. (2016) Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study. EBioMedicine 7, pages 73-79.
Crossref
Crossref
Susanne Schüler-Toprak, Stephan Seitz & Olaf Ortmann. (2016) Endocrine interventions in women with BRCA1/2 mutationsEndokrine Interventionen bei Frauen mit BRCA-1/2-Mutation. Der Gynäkologe 49:5, pages 348-356.
Crossref
Crossref
Laure Dossus & Patrick R Benusiglio. (2015) Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Research 17:1.
Crossref
Crossref
Søren Friis, Ausrele Kesminiene, Carolina Espina, Anssi Auvinen, Kurt Straif & Joachim Schüz. (2015) European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer. Cancer Epidemiology 39, pages S107-S119.
Crossref
Crossref
Byung Ho Son, Laura S Dominici, Fatih Aydogan, Lawrence N Shulman, Sei Hyn Ahn, Ja Young Cho, Suzanne B Coopey, Sung Bae Kim, H Elise Min, Monica Valero, Jiping Wang, Diana Caragacianu, Gyung-yub Gong, Nathanael D Hevelone, Seunghee Baek & Mehra Golshan. (2015) Young Women with Breast Cancer in the United States and South Korea: Comparison of Demographics, Pathology and Management. Asian Pacific Journal of Cancer Prevention 16:6, pages 2531-2535.
Crossref
Crossref
Lino Del Pup, Massimiliano Berretta, Raffaele Di Francia, Carla Cavaliere, Marilena Di Napoli, Gaetano Facchini, Francesco Fiorica, Mario Mileto & Adolf E. Schindler. (2014) Nomegestrol acetate/estradiol hormonal oral contraceptive and breast cancer risk. Anti-Cancer Drugs 25:7, pages 745-750.
Crossref
Crossref
Joanne Kotsopoulos, Jan Lubinski, Pal Moller, Henry T. Lynch, Christian F. Singer, Charis Eng, Susan L. Neuhausen, Beth Karlan, Charmaine Kim-Sing, Tomasz Huzarski, Jacek Gronwald, Jeanna McCuaig, Leigha Senter, Nadine Tung, Parviz Ghadirian, Andrea Eisen, Dawna Gilchrist, Joanne L. Blum, Dana Zakalik, Tuya Pal, Ping Sun & Steven A. Narod. (2014) Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Research and Treatment 143:3, pages 579-586.
Crossref
Crossref
Theodoros N. Sergentanis, Andreas-Antonios Diamantaras, Christina Perlepe, Prodromos Kanavidis, Alkistis Skalkidou & Eleni Th. Petridou. (2014) IVF and breast cancer: a systematic review and meta-analysis. Human Reproduction Update 20:1, pages 106-123.
Crossref
Crossref